Key result
High frequency heart rate variability predicted 30-second chair-stand test performance in women breast cancer survivors, regardless of age and time after diagnosis.
Why the study?
Breast cancer treatments can cause neuromuscular and skeletal disorders, prompting evaluation of the relationship between heart rate variability and functional fitness parameters in female survivors.
Does heart rate variability correlate with functional fitness in breast cancer survivors?
Cross-Sectional (n=25)
Does heart rate variability correlate with functional fitness in breast cancer survivors?
High frequency heart rate variability may serve as a non-invasive clinical indicator of functional fitness in breast cancer survivors.
May support HRV monitoring for fitness assessment in survivors; leaves open prospective validation before clinical adoption.
BACKGROUND: Breast cancer is the most common malignancy among women worldwide. The treatments may also cause neuromuscular and skeletal disorders; therefore, the aim of this study was to verify the existence of a relationship between heart rate variability and different functional fitness parameters in women survivors of breast cancer. METHODS: This cross-sectional study included 25 women survivors of breast cancer, with a mean ± SD age, height, and body mass of 50.8 ± 8.8 years, 1.6 ± 0.7 m, and 67.1 ± 12.3 kg, respectively. Patients underwent measurements of heart rate variability with time and frequency domain analyses, as well as a "30 s chair-stand test", "6 min walking test", "timed up and go test", and "ball throwing test". RESULTS: = 0.21) of the "30 s chair-stand test" performance. CONCLUSION: The findings of this study highlight high frequency as a predictor of "30 s chair-stand test" performance, regardless of age and time after diagnosis, suggesting its usefulness as a clinical indicator of functionality in breast cancer survivors. This study presents a straightforward and non-invasive methodology predicting functional fitness in women breast cancer survivors potentially applicable to clinical practice.
No takes yet. Share an insight, caveat, or question.
Martins et al. (2021) conducted a cross-sectional in Breast cancer (n=25). Heart rate variability (high frequency) was evaluated on 30 s chair-stand test performance. High frequency heart rate variability predicted 30-second chair-stand test performance in women breast cancer survivors, regardless of age and time after diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: